Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera
Clinical trial NCT06290765 · WITHDRAWN
Trial details
- NCT number
- NCT06290765
- Sponsor
- PharmaEssentia
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2026-12-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.